메뉴 건너뛰기




Volumn 62, Issue 2, 2007, Pages 134-141

The limitations of severe asthma: The results of a European survey

Author keywords

Severe asthma; Telephone survey

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; LONG ACTING DRUG; SHORT ACTING DRUG;

EID: 33846136095     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01304.x     Document Type: Article
Times cited : (44)

References (35)
  • 1
    • 9244231156 scopus 로고    scopus 로고
    • Asthma severity: The patient's perspective
    • Yawn BP, Fryer GE, Lanier D. Asthma severity: the patient's perspective. J Asthma 2004;41:623-630.
    • (2004) J Asthma , vol.41 , pp. 623-630
    • Yawn, B.P.1    Fryer, G.E.2    Lanier, D.3
  • 2
    • 33846175483 scopus 로고    scopus 로고
    • Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention NIH Publication No 02-3659 Issued January 1995 (updated 2005). Available at http://www.ginasthma.org.
    • Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention NIH Publication No 02-3659 Issued January 1995 (updated 2005). Available at http://www.ginasthma.org.
  • 3
    • 0037313809 scopus 로고    scopus 로고
    • British guideline on the management of asthma
    • British Thoracic Society, Scottish Intercollegiate Guidelines Network
    • British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003;58(Suppl. 1):i1-i94.
    • (2003) Thorax , vol.58 , Issue.SUPPL. 1
  • 4
    • 0034523602 scopus 로고    scopus 로고
    • Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe
    • Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe. Eur Respir J 2000;16:802-807.
    • (2000) Eur Respir J , vol.16 , pp. 802-807
    • Rabe, K.F.1    Vermeire, P.A.2    Soriano, J.B.3    Maier, W.C.4
  • 7
    • 33745596102 scopus 로고    scopus 로고
    • Attitudes and actions of asthma patients on regular maintenance therapy: The INSPIRE study
    • Partridge MR, Molen TV, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: The INSPIRE study. BMC Pulm Med 2006;6:13.
    • (2006) BMC Pulm Med , vol.6 , pp. 13
    • Partridge, M.R.1    Molen, T.V.2    Myrseth, S.E.3    Busse, W.W.4
  • 8
    • 33646940431 scopus 로고    scopus 로고
    • Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment
    • Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment. Respir Med 2006;100:1139-1151.
    • (2006) Respir Med , vol.100 , pp. 1139-1151
    • Peters, S.P.1    Ferguson, G.2    Deniz, Y.3    Reisner, C.4
  • 9
    • 0036246458 scopus 로고    scopus 로고
    • The burden of asthma with specific reference to the United States
    • Beasley R. The burden of asthma with specific reference to the United States. J Allergy Clin Immunol 2002;109(Suppl. 5):S482-S489.
    • (2002) J Allergy Clin Immunol , vol.109 , Issue.SUPPL. 5
    • Beasley, R.1
  • 10
    • 2542465414 scopus 로고    scopus 로고
    • European Respiratory Society and the European Lung Foundation, Brussels: European Respiratory Society and the European Lung Foundation
    • European Respiratory Society and the European Lung Foundation. European Lung White Book. Brussels: European Respiratory Society and the European Lung Foundation, 2003.
    • (2003) European Lung White Book
  • 11
    • 33644843655 scopus 로고    scopus 로고
    • Evaluation of omalizumab from a health plan perspective
    • Belliveau PP, Lahoz MR. Evaluation of omalizumab from a health plan perspective. J Manag Care Pharm 2005;11:735-745.
    • (2005) J Manag Care Pharm , vol.11 , pp. 735-745
    • Belliveau, P.P.1    Lahoz, M.R.2
  • 12
    • 13244284840 scopus 로고    scopus 로고
    • Asthma economics: Focusing on therapies that improve costly outcomes
    • Gendo K, Lodewick MJ. Asthma economics: focusing on therapies that improve costly outcomes. Curr Opin Pulm Med 2005;11:43-50.
    • (2005) Curr Opin Pulm Med , vol.11 , pp. 43-50
    • Gendo, K.1    Lodewick, M.J.2
  • 13
    • 33846132690 scopus 로고    scopus 로고
    • European Federation of Allergy and Airway Diseases Patients Associations EFA, Accessed 10 January
    • European Federation of Allergy and Airway Diseases Patients Associations (EFA). A European patient perspective on severe asthma. http://www.efanet.org (Accessed 10 January 2006).
    • (2006) A European patient perspective on severe asthma
  • 14
  • 15
    • 0031913201 scopus 로고    scopus 로고
    • Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients
    • Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest 1998;113:587-592.
    • (1998) Chest , vol.113 , pp. 587-592
    • Boulet, L.P.1
  • 16
    • 2442497188 scopus 로고    scopus 로고
    • We are the experts: People with asthma talk about their medicine information needs
    • Raynor DK, Savage I, Knapp P, Henley J. We are the experts: people with asthma talk about their medicine information needs. Patient Educ Couns 2004;53:167-174.
    • (2004) Patient Educ Couns , vol.53 , pp. 167-174
    • Raynor, D.K.1    Savage, I.2    Knapp, P.3    Henley, J.4
  • 18
    • 2942652577 scopus 로고    scopus 로고
    • Parents' experiences of asthma: Process from chaos to coping
    • Trollvik A, Severinsson E. Parents' experiences of asthma: process from chaos to coping. Nurs Health Sci 2004;6:93-99.
    • (2004) Nurs Health Sci , vol.6 , pp. 93-99
    • Trollvik, A.1    Severinsson, E.2
  • 19
    • 14944374738 scopus 로고    scopus 로고
    • Involvement in treatment decisions: What do adults with asthma want and what do they get? Results of a cross sectional survey
    • Caress A-L, Beaver K, Luker K, Campbell M, Woodcock A. Involvement in treatment decisions: what do adults with asthma want and what do they get? Results of a cross sectional survey. Thorax 2005;60:199-205.
    • (2005) Thorax , vol.60 , pp. 199-205
    • Caress, A.-L.1    Beaver, K.2    Luker, K.3    Campbell, M.4    Woodcock, A.5
  • 22
    • 0032565364 scopus 로고    scopus 로고
    • Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC
    • The International Study of Asthma and Allergies in Childhood ISAAC
    • The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-1232.
    • (1998) Lancet , vol.351 , pp. 1225-1232
  • 23
    • 0029995516 scopus 로고    scopus 로고
    • Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS)
    • European Community Respiratory Health Survey ECRHS
    • European Community Respiratory Health Survey (ECRHS). Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687-695.
    • (1996) Eur Respir J , vol.9 , pp. 687-695
  • 24
    • 0032790711 scopus 로고    scopus 로고
    • Psychological factors in severe chronic asthma
    • Vamos M, Kolbe J. Psychological factors in severe chronic asthma. Aust N Z J Psychiatry 1999;33:538-544.
    • (1999) Aust N Z J Psychiatry , vol.33 , pp. 538-544
    • Vamos, M.1    Kolbe, J.2
  • 27
    • 20044362008 scopus 로고    scopus 로고
    • Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
    • Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005;60:309-316.
    • (2005) Allergy , vol.60 , pp. 309-316
    • Humbert, M.1    Beasley, R.2    Ayres, J.3    Slavin, R.4    Hébert, J.5    Bousquet, J.6
  • 29
    • 33645129109 scopus 로고    scopus 로고
    • Outcomes of a Web-based patient education program for asthmatic children and adolescents
    • Runge C, Lecheler J, Horn M, Tews JT, Schaefer M. Outcomes of a Web-based patient education program for asthmatic children and adolescents. Chest 2006;129:581-593.
    • (2006) Chest , vol.129 , pp. 581-593
    • Runge, C.1    Lecheler, J.2    Horn, M.3    Tews, J.T.4    Schaefer, M.5
  • 32
    • 33646016304 scopus 로고    scopus 로고
    • Recent advances in asthma management
    • Amado MC, Portnoy JM. Recent advances in asthma management. Mo Med 2006;103:60-64.
    • (2006) Mo Med , vol.103 , pp. 60-64
    • Amado, M.C.1    Portnoy, J.M.2
  • 33
    • 4444343344 scopus 로고    scopus 로고
    • A cost-effectiveness analysis of a peak flow-based asthma education and self-management plan in a high-cost population
    • de Asis ML, Greene R. A cost-effectiveness analysis of a peak flow-based asthma education and self-management plan in a high-cost population. J Asthma 2004;41:559-565.
    • (2004) J Asthma , vol.41 , pp. 559-565
    • de Asis, M.L.1    Greene, R.2
  • 34
    • 29444460683 scopus 로고    scopus 로고
    • Action plans in asthma
    • Action plans in asthma. Drug Ther Bull 2005;43:91-94.
    • (2005) Drug Ther Bull , vol.43 , pp. 91-94
  • 35
    • 1342304243 scopus 로고    scopus 로고
    • The Living & Breathing Study: A study of patients' views of asthma and its treatment
    • Haughney J, Barnes G, Partridge M, Cleland J. The Living & Breathing Study: a study of patients' views of asthma and its treatment. Prim Care Respir J 2004;13:28-35.
    • (2004) Prim Care Respir J , vol.13 , pp. 28-35
    • Haughney, J.1    Barnes, G.2    Partridge, M.3    Cleland, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.